Rosemary Cunningham-Thomas

CEO

Rosemary Cunningham-Thomas, Chief Executive Officer at Episurf Medical AB

Rosemary is a board level CEO with substantial med-tech experience and a demonstrable track record of consistent financial performance, strategic growth & technology innovation across NYSE, FTSE 100 and early stage, high growth healthcare VC investments.

Rosemary has held positions of increasing responsibility with each successive appointment including six statutory directorships at board level. She has worked across complex global matrix structures where her ability to influence and collaborate with R&D, QA, and manufacturing ensured game changing product launches. She has represented the UK Urology industry on the Part IX Drug Tariff Committee and has worked with NICE, Public Health England, Diabetes UK, NHS Purchasing Authority, UK Competition Commission, ABHI and many of the Royal and European Medical Colleges and professional associations on a multitude of clinical and policy issues.